NIR-PIT has been used to target various cancer-specific proteins, such as epidermal growth factor receptor (EGFR) [8,9,10,11,12,13] and human epidermal growth factor receptor-2 (HER2) [14,15,16,17,18,19], and both have shown excellent anti-cancer effects. The gene discussed is ERBB2; the disease is cancer.